Mark A. Raffeld
National Institutes of Health · 779 works · 47,554 citations · h-index 113
Top works
- Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
- Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
- Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
- Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma
- Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1
- Activated STING in a Vascular and Pulmonary Syndrome
- Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region
- EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression
- Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer.
- p53 mutation is associated with progression in follicular lymphomas
- Detection of occult follicular lymphoma by specific DNA amplification
- The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
- bcl-1, t(11;14), and mantle cell-derived lymphomas [editorial]
- Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
- Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
- Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis
- Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation
- B-cell Maturation Antigen Is a Promising Target for Adoptive T-cell Therapy of Multiple Myeloma
- Pulmonary Nontuberculous Mycobacterial Disease
- Hepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell origin